Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma.

CONTEXT The outcome prediction for renal cell cancer (RCC) remains controversial, and although many parameters have been tested for prognostic significance, only a few have achieved widespread acceptance in clinical practice. The TNM staging system defines local extension of the primary tumour (T), involvement of regional lymph nodes (N), and presence of distant metastases (M). OBJECTIVE This review focuses on reassessing the current TNM staging system for RCC. EVIDENCE ACQUISITION A literature search in English was performed using the National Library of Medicine database and the following keywords: renal cell cancer, kidney neoplasm, and staging. We scrutinized 1952 references, and 62 were selected for review based on their pertinence, study size, and overall contribution to the field. EVIDENCE SYNTHESIS The prognostic significance of tumour size for localized RCC has been investigated in a large number of studies. As a consequence, many modifications of the TNM staging system were primarily made to the size cut points between stage I and II tumours. The latest three revisions of the TNM system are systematically reviewed. For the heterogeneous group of locally advanced RCCs, involving different anatomic structures surrounding the kidney, the situation is still the subject of controversial scientific dispute. In detail, perirenal fat invasion, direct infiltration of the ipsilateral adrenal gland, invasion of the urinary collecting system, infiltration of renal sinus fat, and vena cava and renal vein thrombosis are disputed. Finally, staging of lymph node metastases and distant metastatic disease is discussed. CONCLUSIONS Special emphasis should be put on renal sinus invasion for stage evaluation. Retrospective studies relying on material collected at a time when no emphasis was placed on adequate sampling of the renal sinus should be treated with caution. In view of new treatment opportunities, the current TNM staging system of RCC and any other staging system must be dynamic.

[1]  A. Thackray,et al.  Parenchymal carcinoma of the kidney. , 1949, British journal of urology.

[2]  D. Jacqmin,et al.  Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. , 2009, European urology.

[3]  Impact of tumor size on the clinical outcomes of patients with Robson Stage I renal cell carcinoma , 1999, Cancer.

[4]  P. Karakiewicz,et al.  Treatment of metastatic renal cell carcinoma , 2010, Nature Reviews Urology.

[5]  B. Delahunt,et al.  Histopathologic prognostic indicators for renal cell carcinoma. , 1998, Seminars in diagnostic pathology.

[6]  K. Bensalah,et al.  Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. , 2007, European urology.

[7]  V. Ficarra,et al.  Incidental detection beyond pathological factors as prognostic predictor of renal cell carcinoma. , 2003, European urology.

[8]  J. Srigley,et al.  Current prognostic factors‐renal cell carcinoma , 1997 .

[9]  Jacques Tostain,et al.  Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. , 2004, The Journal of urology.

[10]  J. Mazeron,et al.  TNM classification of malignant tumours (5 e dition) , 1998 .

[11]  N. Rioux-Leclercq,et al.  A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients. , 2007, The Journal of urology.

[12]  B. Delahunt,et al.  Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma , 2002, Cancer.

[13]  Choung-Soo Kim,et al.  Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. , 2008, The Journal of urology.

[14]  L. Kavoussi,et al.  Pathological stage does not alter the prognosis for renal lesions determined to be stage T1 by computerized tomography. , 2005, The Journal of urology.

[15]  B. Churchill,et al.  The results of radical nephrectomy for renal cell carcinoma. , 1968, Transactions of the American Association of Genito-Urinary Surgeons.

[16]  A. Novick,et al.  Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. , 1999, The Journal of urology.

[17]  R. Motzer,et al.  Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Lam,et al.  Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma , 2007, BJU international.

[19]  J. Cheville,et al.  Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? , 2005, The Journal of urology.

[20]  A. Sagalowsky,et al.  Reassessment of the 1997 TNM classification system for renal cell carcinoma , 2003, Cancer.

[21]  V. Ficarra,et al.  Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome. , 2007, European urology.

[22]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[23]  B. Delahunt,et al.  Classification of renal cell carcinoma , 1997, Cancer.

[24]  A. Moinzadeh,et al.  Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? , 2004, The Journal of urology.

[25]  J. Cheville,et al.  Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. , 2004, The Journal of urology.

[26]  V. Margulis,et al.  Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. , 2007, The Journal of urology.

[27]  L. Sobin,et al.  The process for continuous improvement of the TNM classification , 2004, Cancer.

[28]  Amanjot S. Sethi,et al.  Pathologic upstaging after laparoscopic radical nephrectomy. , 2008, Journal of endourology.

[29]  Ch. Wittekind,et al.  TNM supplement : a commentary on uniform use , 2003 .

[30]  C. J. Robson Radical nephrectomy for renal cell carcinoma. , 1963, The Journal of urology.

[31]  J. Cheville,et al.  A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. , 2005, The Journal of urology.

[32]  Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma. , 2004 .

[33]  J. Cheville,et al.  Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma. , 2005, The Journal of urology.

[34]  M. Stöckle,et al.  Current TNM classification of renal cell carcinoma evaluated: revising stage T3a. , 2005, The Journal of urology.

[35]  J. Cheville,et al.  Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? , 2005, The Journal of urology.

[36]  S. Petković An anatomical classification of renal tumors in the adult as a basis for prognosis. , 1959, The Journal of urology.

[37]  A. Novick,et al.  Nephron sparing surgery for renal tumors: indications, techniques and outcomes. , 2001, The Journal of urology.

[38]  H. Moch,et al.  Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma , 2000, Cancer.

[39]  K. Bensalah,et al.  The changing evolution of renal tumours: a single center experience over a two-decade period. , 2004, European urology.

[40]  B. Ljungberg Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881 , 2009 .

[41]  E. Bollito,et al.  Reassessing the current TNM lymph node staging for renal cell carcinoma. , 2006, European urology.

[42]  J. Cheville,et al.  A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma. , 2005, Clinics in laboratory medicine.

[43]  J. Cheville,et al.  Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? , 2005, The Journal of urology.

[44]  F. Guillé,et al.  Proposal for revision of the TNM classification system for renal cell carcinoma , 2005, Cancer.

[45]  S. Jung,et al.  Reappraisal of T3N0/NxM0 renal cell carcinoma: significance of extent of fat invasion, renal vein invasion, and adrenal invasion. , 2008, Human pathology.

[46]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[47]  S. Bonsib Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases , 2006, Modern Pathology.

[48]  S. Bonsib,et al.  Renal sinus involvement in renal cell carcinomas. , 2000, The American journal of surgical pathology.

[49]  G. Martignoni,et al.  TNM staging system for renal-cell carcinoma: current status and future perspectives. , 2007, The Lancet. Oncology.

[50]  V. Ficarra,et al.  Neoplasm staging and organ-confined renal cell carcinoma: a systematic review. , 2004, European urology.

[51]  S. Pahernik,et al.  Prognostic stratification of localized renal cell carcinoma by tumor size. , 2008, The Journal of urology.

[52]  R. Flocks,et al.  Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more. , 1958, The Journal of urology.

[53]  R. Figlin,et al.  TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. , 2003, The Journal of urology.

[54]  M. Blute,et al.  Pathologic staging of renal cell carcinoma , 2001, Cancer.

[55]  F. Guillé,et al.  Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience. , 2007, European urology.

[56]  A. Antonelli,et al.  Nephron-Sparing Surgery versus Radical Nephrectomy in the Treatment of Intracapsular Renal Cell Carcinoma up to 7 cm , 2008 .

[57]  S. Bonsib Renal veins and venous extension in clear cell renal cell carcinoma , 2007, Modern Pathology.

[58]  A. Buzaid,et al.  Exploring the role of novel agents in the treatment of renal cell carcinoma. , 2008, Cancer treatment reviews.

[59]  R. Figlin,et al.  Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? , 2004, The Journal of urology.

[60]  R. Figlin,et al.  Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome. , 2001, The Journal of urology.

[61]  A. Tizzani,et al.  Proposal of an improved prognostic classification for pT3 renal cell carcinoma. , 2008, The Journal of urology.

[62]  F. Guillé,et al.  Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma , 2005, Cancer.

[63]  J. Cheville,et al.  Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy , 2005, Cancer.